Selected research
Market Analysis & Forecast
Global G-protein Coupled Receptor Market Analysis and Forecast 2026-2032
Market perspective
The global G-protein Coupled Receptor market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for G-protein Coupled Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for G-protein Coupled Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for G-protein Coupled Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for G-protein Coupled Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of G-protein Coupled Receptor include Abcam plc, Becton, Dickinson, Cisbio Bioassays, DiscoveRx Corporation, EMD Millipore, Enzo Life Sciences, Inc., HD Biosciences Co. Ltd., PerkinElmer, Inc. and Promega Corporation, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for G-protein Coupled Receptor, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of G-protein Coupled Receptor, also provides the revenue of main regions and countries. Of the upcoming market potential for G-protein Coupled Receptor, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the G-protein Coupled Receptor revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global G-protein Coupled Receptor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for G-protein Coupled Receptor revenue, projected growth trends, production technology, application and end-user industry.
G-protein Coupled Receptor Segment by Company
Abcam plc
Becton, Dickinson
Cisbio Bioassays
DiscoveRx Corporation
EMD Millipore
Enzo Life Sciences, Inc.
HD Biosciences Co. Ltd.
PerkinElmer, Inc.
Promega Corporation
Qiagen
AbbVie
Thermo Fisher Scientific, Inc.
Abbott
G-protein Coupled Receptor Segment by Type
cAMP Assays
cGMP Assays
GTPγS Binding Assays
Reporter Gene Assays
Calcium Level Detection Assays
Receptor Internalization Assays
G-protein Coupled Receptor Segment by Application
Oncology
Central Nervous System
Cardiovascular System
Reproductive System
Immune System
Respiratory System
Others
G-protein Coupled Receptor Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global G-protein Coupled Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of G-protein Coupled Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of G-protein Coupled Receptor.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of G-protein Coupled Receptor in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of G-protein Coupled Receptor company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, G-protein Coupled Receptor revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- cAMP Assays
- cGMP Assays
- GTPγS Binding Assays
- Reporter Gene Assays
- Calcium Level Detection Assays
- Receptor Internalization Assays
Applications
- Oncology
- Central Nervous System
- Cardiovascular System
- Reproductive System
- Immune System
- Respiratory System
- Others
Companies covered
- Abcam plc
- Becton, Dickinson
- Cisbio Bioassays
- DiscoveRx Corporation
- EMD Millipore
- Enzo Life Sciences, Inc.
- HD Biosciences Co. Ltd.
- PerkinElmer, Inc.
- Promega Corporation
- Qiagen
- AbbVie
- Thermo Fisher Scientific, Inc.
- Abbott
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 G-protein Coupled Receptor Market by Type
- 1.2.1 Global G-protein Coupled Receptor Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 cAMP Assays
- 1.2.3 cGMP Assays
- 1.2.4 GTPγS Binding Assays
- 1.2.5 Reporter Gene Assays
- 1.2.6 Calcium Level Detection Assays
- 1.2.7 Receptor Internalization Assays
- 1.3 G-protein Coupled Receptor Market by Application
- 1.3.1 Global G-protein Coupled Receptor Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Oncology
- 1.3.3 Central Nervous System
- 1.3.4 Cardiovascular System
- 1.3.5 Reproductive System
- 1.3.6 Immune System
- 1.3.7 Respiratory System
- 1.3.8 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 G-protein Coupled Receptor Market Dynamics
- 2.1 G-protein Coupled Receptor Industry Trends
- 2.2 G-protein Coupled Receptor Industry Drivers
- 2.3 G-protein Coupled Receptor Industry Opportunities and Challenges
- 2.4 G-protein Coupled Receptor Industry Restraints
3 Global Growth Perspective
- 3.1 Global G-protein Coupled Receptor Market Perspective (2021-2032)
- 3.2 Global G-protein Coupled Receptor Growth Trends by Region
- 3.2.1 Global G-protein Coupled Receptor Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global G-protein Coupled Receptor Market Size by Region (2021-2026)
- 3.2.3 Global G-protein Coupled Receptor Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global G-protein Coupled Receptor Revenue by Players
- 4.1.1 Global G-protein Coupled Receptor Revenue by Players (2021-2026)
- 4.1.2 Global G-protein Coupled Receptor Revenue Market Share by Players (2021-2026)
- 4.1.3 Global G-protein Coupled Receptor Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global G-protein Coupled Receptor Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global G-protein Coupled Receptor Key Players Headquarters & Area Served
- 4.4 Global G-protein Coupled Receptor Players, Product Type & Application
- 4.5 Global G-protein Coupled Receptor Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global G-protein Coupled Receptor Market CR5 and HHI
- 4.6.3 2025 G-protein Coupled Receptor Tier 1, Tier 2, and Tier 3
5 G-protein Coupled Receptor Market Size by Type
- 5.1 Global G-protein Coupled Receptor Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global G-protein Coupled Receptor Revenue by Type (2021-2032)
- 5.3 Global G-protein Coupled Receptor Revenue Market Share by Type (2021-2032)
6 G-protein Coupled Receptor Market Size by Application
- 6.1 Global G-protein Coupled Receptor Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global G-protein Coupled Receptor Revenue by Application (2021-2032)
- 6.3 Global G-protein Coupled Receptor Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Abcam plc
- 7.1.1 Abcam plc Company Information
- 7.1.2 Abcam plc Business Overview
- 7.1.3 Abcam plc G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
- 7.1.4 Abcam plc G-protein Coupled Receptor Product Portfolio
- 7.1.5 Abcam plc Recent Developments
- 7.2 Becton, Dickinson
- 7.2.1 Becton, Dickinson Company Information
- 7.2.2 Becton, Dickinson Business Overview
- 7.2.3 Becton, Dickinson G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
- 7.2.4 Becton, Dickinson G-protein Coupled Receptor Product Portfolio
- 7.2.5 Becton, Dickinson Recent Developments
- 7.3 Cisbio Bioassays
- 7.3.1 Cisbio Bioassays Company Information
- 7.3.2 Cisbio Bioassays Business Overview
- 7.3.3 Cisbio Bioassays G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
- 7.3.4 Cisbio Bioassays G-protein Coupled Receptor Product Portfolio
- 7.3.5 Cisbio Bioassays Recent Developments
- 7.4 DiscoveRx Corporation
- 7.4.1 DiscoveRx Corporation Company Information
- 7.4.2 DiscoveRx Corporation Business Overview
- 7.4.3 DiscoveRx Corporation G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
- 7.4.4 DiscoveRx Corporation G-protein Coupled Receptor Product Portfolio
- 7.4.5 DiscoveRx Corporation Recent Developments
- 7.5 EMD Millipore
- 7.5.1 EMD Millipore Company Information
- 7.5.2 EMD Millipore Business Overview
- 7.5.3 EMD Millipore G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
- 7.5.4 EMD Millipore G-protein Coupled Receptor Product Portfolio
- 7.5.5 EMD Millipore Recent Developments
- 7.6 Enzo Life Sciences, Inc.
- 7.6.1 Enzo Life Sciences, Inc. Company Information
- 7.6.2 Enzo Life Sciences, Inc. Business Overview
- 7.6.3 Enzo Life Sciences, Inc. G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
- 7.6.4 Enzo Life Sciences, Inc. G-protein Coupled Receptor Product Portfolio
- 7.6.5 Enzo Life Sciences, Inc. Recent Developments
- 7.7 HD Biosciences Co. Ltd.
- 7.7.1 HD Biosciences Co. Ltd. Company Information
- 7.7.2 HD Biosciences Co. Ltd. Business Overview
- 7.7.3 HD Biosciences Co. Ltd. G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
- 7.7.4 HD Biosciences Co. Ltd. G-protein Coupled Receptor Product Portfolio
- 7.7.5 HD Biosciences Co. Ltd. Recent Developments
- 7.8 PerkinElmer, Inc.
- 7.8.1 PerkinElmer, Inc. Company Information
- 7.8.2 PerkinElmer, Inc. Business Overview
- 7.8.3 PerkinElmer, Inc. G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
- 7.8.4 PerkinElmer, Inc. G-protein Coupled Receptor Product Portfolio
- 7.8.5 PerkinElmer, Inc. Recent Developments
- 7.9 Promega Corporation
- 7.9.1 Promega Corporation Company Information
- 7.9.2 Promega Corporation Business Overview
- 7.9.3 Promega Corporation G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
- 7.9.4 Promega Corporation G-protein Coupled Receptor Product Portfolio
- 7.9.5 Promega Corporation Recent Developments
- 7.10 Qiagen
- 7.10.1 Qiagen Company Information
- 7.10.2 Qiagen Business Overview
- 7.10.3 Qiagen G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
- 7.10.4 Qiagen G-protein Coupled Receptor Product Portfolio
- 7.10.5 Qiagen Recent Developments
- 7.11 AbbVie
- 7.11.1 AbbVie Company Information
- 7.11.2 AbbVie Business Overview
- 7.11.3 AbbVie G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
- 7.11.4 AbbVie G-protein Coupled Receptor Product Portfolio
- 7.11.5 AbbVie Recent Developments
- 7.12 Thermo Fisher Scientific, Inc.
- 7.12.1 Thermo Fisher Scientific, Inc. Company Information
- 7.12.2 Thermo Fisher Scientific, Inc. Business Overview
- 7.12.3 Thermo Fisher Scientific, Inc. G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
- 7.12.4 Thermo Fisher Scientific, Inc. G-protein Coupled Receptor Product Portfolio
- 7.12.5 Thermo Fisher Scientific, Inc. Recent Developments
- 7.13 Abbott
- 7.13.1 Abbott Company Information
- 7.13.2 Abbott Business Overview
- 7.13.3 Abbott G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
- 7.13.4 Abbott G-protein Coupled Receptor Product Portfolio
- 7.13.5 Abbott Recent Developments
8 North America
- 8.1 North America G-protein Coupled Receptor Revenue (2021-2032)
- 8.2 North America G-protein Coupled Receptor Revenue by Type (2021-2032)
- 8.2.1 North America G-protein Coupled Receptor Revenue by Type (2021-2026)
- 8.2.2 North America G-protein Coupled Receptor Revenue by Type (2027-2032)
- 8.3 North America G-protein Coupled Receptor Revenue Share by Type (2021-2032)
- 8.4 North America G-protein Coupled Receptor Revenue by Application (2021-2032)
- 8.4.1 North America G-protein Coupled Receptor Revenue by Application (2021-2026)
- 8.4.2 North America G-protein Coupled Receptor Revenue by Application (2027-2032)
- 8.5 North America G-protein Coupled Receptor Revenue Share by Application (2021-2032)
- 8.6 North America G-protein Coupled Receptor Revenue by Country
- 8.6.1 North America G-protein Coupled Receptor Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America G-protein Coupled Receptor Revenue by Country (2021-2026)
- 8.6.3 North America G-protein Coupled Receptor Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe G-protein Coupled Receptor Revenue (2021-2032)
- 9.2 Europe G-protein Coupled Receptor Revenue by Type (2021-2032)
- 9.2.1 Europe G-protein Coupled Receptor Revenue by Type (2021-2026)
- 9.2.2 Europe G-protein Coupled Receptor Revenue by Type (2027-2032)
- 9.3 Europe G-protein Coupled Receptor Revenue Share by Type (2021-2032)
- 9.4 Europe G-protein Coupled Receptor Revenue by Application (2021-2032)
- 9.4.1 Europe G-protein Coupled Receptor Revenue by Application (2021-2026)
- 9.4.2 Europe G-protein Coupled Receptor Revenue by Application (2027-2032)
- 9.5 Europe G-protein Coupled Receptor Revenue Share by Application (2021-2032)
- 9.6 Europe G-protein Coupled Receptor Revenue by Country
- 9.6.1 Europe G-protein Coupled Receptor Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe G-protein Coupled Receptor Revenue by Country (2021-2026)
- 9.6.3 Europe G-protein Coupled Receptor Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China G-protein Coupled Receptor Revenue (2021-2032)
- 10.2 China G-protein Coupled Receptor Revenue by Type (2021-2032)
- 10.2.1 China G-protein Coupled Receptor Revenue by Type (2021-2026)
- 10.2.2 China G-protein Coupled Receptor Revenue by Type (2027-2032)
- 10.3 China G-protein Coupled Receptor Revenue Share by Type (2021-2032)
- 10.4 China G-protein Coupled Receptor Revenue by Application (2021-2032)
- 10.4.1 China G-protein Coupled Receptor Revenue by Application (2021-2026)
- 10.4.2 China G-protein Coupled Receptor Revenue by Application (2027-2032)
- 10.5 China G-protein Coupled Receptor Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia G-protein Coupled Receptor Revenue (2021-2032)
- 11.2 Asia G-protein Coupled Receptor Revenue by Type (2021-2032)
- 11.2.1 Asia G-protein Coupled Receptor Revenue by Type (2021-2026)
- 11.2.2 Asia G-protein Coupled Receptor Revenue by Type (2027-2032)
- 11.3 Asia G-protein Coupled Receptor Revenue Share by Type (2021-2032)
- 11.4 Asia G-protein Coupled Receptor Revenue by Application (2021-2032)
- 11.4.1 Asia G-protein Coupled Receptor Revenue by Application (2021-2026)
- 11.4.2 Asia G-protein Coupled Receptor Revenue by Application (2027-2032)
- 11.5 Asia G-protein Coupled Receptor Revenue Share by Application (2021-2032)
- 11.6 Asia G-protein Coupled Receptor Revenue by Country
- 11.6.1 Asia G-protein Coupled Receptor Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia G-protein Coupled Receptor Revenue by Country (2021-2026)
- 11.6.3 Asia G-protein Coupled Receptor Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA G-protein Coupled Receptor Revenue (2021-2032)
- 12.2 SAMEA G-protein Coupled Receptor Revenue by Type (2021-2032)
- 12.2.1 SAMEA G-protein Coupled Receptor Revenue by Type (2021-2026)
- 12.2.2 SAMEA G-protein Coupled Receptor Revenue by Type (2027-2032)
- 12.3 SAMEA G-protein Coupled Receptor Revenue Share by Type (2021-2032)
- 12.4 SAMEA G-protein Coupled Receptor Revenue by Application (2021-2032)
- 12.4.1 SAMEA G-protein Coupled Receptor Revenue by Application (2021-2026)
- 12.4.2 SAMEA G-protein Coupled Receptor Revenue by Application (2027-2032)
- 12.5 SAMEA G-protein Coupled Receptor Revenue Share by Application (2021-2032)
- 12.6 SAMEA G-protein Coupled Receptor Revenue by Country
- 12.6.1 SAMEA G-protein Coupled Receptor Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA G-protein Coupled Receptor Revenue by Country (2021-2026)
- 12.6.3 SAMEA G-protein Coupled Receptor Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst